Skip to main content
John D. Roberts, MD, Hematology, New Haven, CT, Yale-New Haven Hospital

John D.RobertsMD

Hematology New Haven, CT

Sickle Cell & Other Anemias

Professor of Medicine Medical Director, YNHS Adult Sickle Cell Program

Dr. Roberts is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Roberts' full profile

Already have an account?

Education & Training

  • University of Vermont Medical Center
    University of Vermont Medical CenterFellowship, Hematology and Medical Oncology, 1982 - 1984
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Pediatrics, 1979 - 1980
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Internal Medicine/Pediatrics, 1976 - 1980
  • University of North Carolina Hospitals
    University of North Carolina HospitalsInternship, Transitional Year, 1976 - 1977
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1976
  • Harvard University
    Harvard UniversityAB, Social Studies, 1972

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1980 - Present
  • CT State Medical License
    CT State Medical License 2012 - 2024
  • VA State Medical License
    VA State Medical License 1993 - 2012
  • VT State Medical License
    VT State Medical License 1982 - 1994
  • NC State Medical License
    NC State Medical License 1980 - 1984
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hospice and Palliative Medicine
  • American Board of Internal Medicine Medical Oncology
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Harry Hines Award (Community Clinical Oncology Program Principal Investigator of the Year) NCI, 2012
  • Alpha Omega Alpha 2008
  • Fellows Appreciation Award Division of Hematology, Oncology & Palliative Care, Virginia Commonwealth University, 2004

Publications & Presentations

PubMed

Journal Articles

  • The relationship between taste, olfaction, and nutrition in the cancer population  
    Farmer MN, Raddin RS, Roberts JD, J Supportive Onco, 3/1/2009
  • Daily assessment of pain in adults with sickle cell disease  
    Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, Aisiku IP, Levenson JL, Roseff SD, Ann Intern Med., 1/15/2008
  • Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death in vitro and in vivo  
    Hamed H, Hawkins W, Mitchell C, Gilfor D, Zhang G, Pei XY, Dai Y, Hagan MP, Roberts JD, Yacoub A, Grant S, Dent P, Mol Cancer Ther., 1/1/2008
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Baseline Pain in Adults with Sickle Cell Disease Can be Neuropathic or Nociceptive and Outcomes Differ between Pain Types
    John D. Roberts, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Case Management Featuring Community Health Workers Reduces Inpatient Health Care Utilization in Adults with Sickle Cell Disease
    John D. Roberts, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Medical Marijuana Certification for Patients with Sickle Cell Disease: A Survey Study of Patient's Use and Preferences 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • What is “research” in clinical research and who should pay for it? 
    9/27/2011
  • The VCU Adult Sickle Cell Program: service and research. 
    Yale University - 9/19/2011
  • Join now to see all

Grant Support

  • Vcu Minority-Based Community Clinical Oncology ProgramNational Cancer Institute2010–2011
  • Clinical Trial: Combined Treatment With Bortezomib &DacarbazineNational Center For Research Resources2008–2010
  • Clinical Protocol And Data ManagementNational Cancer Institute2008–2010
  • Clinical Trial: Pilot/Phase 1 Study Of Zoledronic Acid (Zometa ) In Sickle CellNational Center For Research Resources2009
  • Clinical Trial: A Phase 2 Study Of AZD6244 In Advanced Or Metastatic HepatocelluNational Center For Research Resources2009
  • Clinical Trial: NCI 6858: A Phase 1 Study Of Suberoylanilide Hydroxamic Acid (SNational Center For Research Resources2008–2009
  • Vcu Minority-Based CCOPNational Cancer Institute1998–2009
  • NCI 6858: A Phase 1 Study Of Suberoylanilide Hydroxamic Acid (SAHA) In CombiNational Center For Research Resources2007
  • Bone Turnover In Sickle Cell DiseaseNational Center For Research Resources2006–2007
  • Combined Treatment With Bortezomib &DacarbazineNational Center For Research Resources2005–2007
  • Regulation Of Human Carcinoma Cell AdhesionNational Institute Of Environmental Health Sciences2003–2006
  • Modulation Of The Bio. Response To IL-2 With BryostatinNational Center For Research Resources2004
  • Core--Clinical Protocol And Data ManagementNational Cancer Institute2002
  • Phase 1 Trial Of Bryostatin And Interleukin-2National Cancer Institute2000–2001
  • LY231514 &Docetaxel Dosing In CancerNational Center For Research Resources1999–2001
  • Effect Of Delta 9 Tetrahydrocannabinol On Morphine Analgesia In NormaNational Center For Research Resources1999–2001
  • Phase I Dose Escalation Of Multiagent Chemotherapy, Leucovorin/GemzarNational Center For Research Resources1998–2001
  • Clinical Study Of 4bm In Sickle Cell DiseaseNational Center For Research Resources1998–2001
  • A Phase I Study Of The Garft Inhibitor Ag2034 In Patients With Advanced CancerNational Center For Research Resources1998–2001
  • Osteoclast Activation And Inhibition In Sickle CellNational Center For Research Resources2000
  • Core--Clinical ResearchNational Cancer Institute1994–2000
  • Phase 1 Study Of Weekly IV Lometrexol With Continuous Oral Folic Acid SupplementNational Center For Research Resources1996–1999
  • MCV Minority-Based CCOPNational Cancer Institute1995–1997
  • Easten Coorperative Oncology GroupNational Cancer Institute1991
  • Platinum Analogs For Cancer ChemotherapyNational Cancer Institute1987–1989

Hospital Affiliations